Both mrProANP and A-FaBP have been proposed as diagnostic and prognostic biomarkers in adults with stroke [16–18] We found higher A-FaBP levels in the septic subjects with neurologic dysfunction, but only MMP-9/TIMP-1 ratio was associated with 6-month outcome. Here, MMP9 is linked to stroke disorder.